Table 4 Predictors of mortality among 11,421 patients
| Â | Mortality | ||
|---|---|---|---|
Unadjusted | Adjusteda | ||
HR (95%CI) | HR (95%CI) | ||
Indigenous status | Indigenous (vs. non-Indigenous) | 1.16 (1.06–1.27) | 1.08 (0.96–1.20) |
Socio-demographic factors | |||
 Age group (years) | 50 years and over (vs. 20–49 years) | 1.69 (1.58–1.80) | 1.57 (1.45–1.69) |
 Gender | Male (vs. Female) | 1.20 (1.14–1.26) | 1.06 (1.00–1.12) |
 Marital status | No partner (vs. Married/De Facto) | 1.12 (1.07–1.18) | 1.07 (1.01–1.13) |
 Rurality of residence | Outside major city (vs. Major city) | 1.17 (1.12–1.23) | 1.13 (1.07–1.20) |
 Socioeconomic advantage and disadvantage | Q4, Q5 (vs. Q1, Q2, Q3) | 1.16 (1.11–1.22) | 1.04 (0.98–1.10) |
Presumed aetiology | |||
 Alcohol |  | 1.33 (1.27–1.40) | 1.06 (0.99–1.14) |
 Cryptogenic/NALFD/NASH |  | 0.87 (0.82–0.91) | 0.93 (0.87–0.99) |
 Chronic HCV/HBV |  | 0.92 (0.86–0.97) | 0.89 (0.83–0.95) |
Comorbidities at index admission | |||
 Charlson comorbidity index | > 0 (at least one comorbidity) vs. 0 (none) | 2.27 (2.16–2.39) | 1.46 (1.36–1.56) |
 Diabetes |  | 1.40 (1.33–1.49) | n/s |
 Cancer |  | 2.79 (2.62–2.96) | 2.59 (2.26–2.97) |
Complications of cirrhosis at index admission | |||
 Ascites |  | 1.81 (1.72–1.90) | 1.47 (1.37–1.57) |
 Gastrointestinal bleeding |  | 0.72 (0.68–0.76) | n/s |
 Hepatocellular carcinoma |  | 2.42 (2.26–2.58) | 0.93 (0.80–1.08) |
Health service use | |||
 Pharmacist |  | 1.56 (1.46–1.66) | 1.08 (1.00–1.16 |
 Dietician |  | 1.64 (1.56–1.73) | 0.95 (0.88–1.02) |
 Social worker |  | 1.95 (1.84–2.06) | 1.28 (1.19–1.38) |
 Occupational therapist |  | 1.93 (1.80–2.04) | n/s |
 Physiotherapist |  | 1.96 (1.86–2.06) | 1.14 (1.07–1.23) |
 Referral source | Emergency department presentation vs. not | 1.78 (1.69–1.87) | 1.56 (1.46–1.67) |